Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Biosimilar Insulin: Why Novo Knows No Fear

Executive Summary

Even after the largest pharmaceutical company in the sector, Pfizer Inc., announced it was laying a stake in the biosimilar insulin market, Danish diabetes leader Novo Nordisk A/S – about one-fifth the size of Pfizer in sales terms, although its market cap is just under half of Pfizer's – didn't flinch.

You may also be interested in...

Price Isn't Enough: Sandoz Hones Biosimilars Strategy With Lessons From Omnitrope

As FDA fleshes out the beginnings of a biosimilar regulatory pathway in the U.S., Novartis AG's generics business Sandoz is starting to draw important lessons in how to effectively commercialize copy-cat biologics.

Pfizer Teams Up With Biocon In Bid to Dominate Global Biosimilar Insulin Market

Pfizer tells analysts the deal will have an incremental not "instrumental" impact on its established products and emerging markets strategy.

Radiopharmaceuticals: A New Frontier In Precision Cancer Therapy

Growing interest in radioligand-based cancer therapies reflects the class’s unique advantages – including the ability to “see what you treat.”


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts